We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE

Expanded access is no longer available for this treatment.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00063791
First Posted: July 8, 2003
Last Update Posted: February 14, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Millennium Pharmaceuticals, Inc.
July 7, 2003
July 8, 2003
February 14, 2007
 
A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE
The purpose of this study is to give patients who have had 4 or more prior lines of therapy for multiple myeloma access to VELCADE. The study is for patients who are not eligible for other clinical trials with VELCADE and for who VELCADE would otherwise not be available.
Not Provided
Expanded Access
Drug: Bortezomib
Not Provided
 
No longer available
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00063791
Not Provided
Millennium Pharmaceuticals, Inc.
Not Provided
Not Provided
Millennium Pharmaceuticals, Inc.
July 2003